1. Home
  2. ALEC vs JONE Comparison

ALEC vs JONE Comparison

Compare ALEC & JONE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alector Inc.

ALEC

Alector Inc.

N/A

Current Price

$2.31

Market Cap

275.8M

Sector

Health Care

ML Signal

N/A

Logo Jones Ventures INTL Acquisition1 Corp Class A Ordinary Shares

JONE

Jones Ventures INTL Acquisition1 Corp Class A Ordinary Shares

N/A

Current Price

$9.86

Market Cap

282.0M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
ALEC
JONE
Founded
2013
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Blank Checks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
275.8M
282.0M
IPO Year
2019
2026

Fundamental Metrics

Financial Performance
Metric
ALEC
JONE
Price
$2.31
$9.86
Analyst Decision
Buy
Analyst Count
8
0
Target Price
★ $4.42
N/A
AVG Volume (30 Days)
★ 1.8M
76.2K
Earning Date
11-05-2026
N/A
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ 0.70
N/A
Revenue
★ $21,045,000.00
N/A
Revenue This Year
$990.25
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.30
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.09
$9.80
52 Week High
$2.84
$9.92

Technical Indicators

Market Signals
Indicator
ALEC
JONE
Relative Strength Index (RSI) 51.94 56.13
Support Level $1.90 $9.81
Resistance Level $2.67 $9.92
Average True Range (ATR) 0.23 0.00
MACD -0.01 0.00
Stochastic Oscillator 37.20 50.00

Price Performance

Historical Comparison
ALEC
JONE

About ALEC Alector Inc.

Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.

About JONE Jones Ventures INTL Acquisition1 Corp Class A Ordinary Shares

Jones Ventures INTL Acquisition1 Corp is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

Share on Social Networks: